CD7 and neoplasm: 89Zr derivatives have also been utilized for in vivo tracking by leveraging 89Zr-labeled F(ab′)2 targeting various T cell markers; for example, CD7, a marker of mature T cells, has been shown in pre-clinical studies to provide a robust signal at the tumor site without impacting T cell function nor tumor rejection.